Page last updated: 2024-08-26

mci 9038 and Vascular Diseases

mci 9038 has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D	1
Fareed, J; Jeske, WP	1

Reviews

1 review(s) available for mci 9038 and Vascular Diseases

Article	Year
Small-molecule direct antithrombins: argatroban. Best practice & research. Clinical haematology, 2004, Volume: 17, Issue:1 Topics: Animals; Antithrombins; Arginine; Hemostasis; Humans; Pipecolic Acids; Sulfonamides; Treatment Outcome; Vascular Diseases	2004

Other Studies

1 other study(ies) available for mci 9038 and Vascular Diseases

Article	Year
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome. American journal of hematology, 2011, Volume: 86, Issue:2 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin	2011

Article

Year

Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.

American journal of hematology, 2011, Volume: 86, Issue:2

Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin

2011